NCT06338358Not yet recruiting
Understanding Participation Habits Among Plaque Psoriasis Patients
In the Patient's Words: Understanding Patient Participation and Engagement in Plaque Psoriasis Clinical Trials
Source: ClinicalTrials.gov · Last updated 29 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study intends to investigate the personal experiences of plaque psoriasis patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all plaque psoriasis as well as those in under-represented demographic groups.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 22 Mar 2024
- Start date
- 1 Apr 2025
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Power Life Sciences Inc.
- Diseases
- Psoriasis
- NCT number
- NCT06338358
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Apr 2025 to the primary completion date, 30 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any serious and/or unstable pre-existing medical disorders
Other
- Refusal of consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Who the study is looking for
- Patients diagnosed with plaque psoriasis
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Power Life Sciences Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.